Is HLS Therapeutics Inc. (HLS.TO) a Buy, Sell, or Hold?
TSX : HLS.TO
HLS Therapeutics Inc. — Competitors
$4.11 CAD
-$0.1 (-2.38%)
- Volume
- 2.26K
- Average Volume
- 35.17K
- Market Capitalization
- $128.54M
- P/E Ratio
- -9.31
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $5.77
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.00
HLS.TO vs. The Competition
| Properties | HLS.TO | BNXT.CN | CRDL.TO | GRIN.CN |
|---|---|---|---|---|
| Market Cap | $128.54M | $40.3M | $200.57M | $137.47M |
| Shares Outstanding | $31.27M | $129.99M | $115.27M | $249.94M |
| P/E Ratio | -9.31 | -4.06 | -4.45 | -118.28 |
| EPS | -0.33 | -0.07 | -0.33 | 0.0 |
| Day Low | 4.11 | 0.305 | 1.72 | 0.53 |
| Day High | 4.2 | 0.34 | 1.85 | 0.6 |
| Year Low | 0.001 | 0.28 | 1.225 | 0.38 |
| Year High | 5.765 | 1.1 | 2.33 | 0.72 |
| Average Price 50 | 4.3879 | 0.3734 | 1.6168 | 0.5924 |
| Average Price 200 | 4.69363 | 0.5583 | 1.54683 | 0.523 |
| Volume | 2264 | 17347 | 104.94K | 87860 |
| Average Volume | - | - | - | - |